Orphazyme Settlement

Claim Deadline: January 17, 2024

Settlement Fund: $25,000,000

Settlement Class

Those who purchased, or otherwise acquired, the American Depositary Shares (“ADS”) of Orphazyme A/S (“Orphazyme”) (NASDAQ: ORPH) in its September 2020 Initial Public Offering (“IPO”) or at any time between September 29, 2020 and November 4, 2021, both dates inclusive (the “Settlement Class Period”), you could be entitled to a payment from a class action settlement (the “Settlement”).

Important Documents

Settlement Status

Preliminarily Approved

Class Period

September 29, 2020 - November 04, 2021

Settlement Hearing Date

February 07, 2024

Opt-Out Deadline

January 17, 2024

Claims Admin

Busic v. Orphazyme A/S, et al.
c/o A.B. Data. Ltd.
P.O. Box 173018
Milwaukee, WI 53217 

Levi & Korsinsky did not act as lead counsel or otherwise participate in litigating the above class action and provides this information to remind class members of the deadline to submit a claim for a share of any of the settlement fund.